Filippatos, G, Anker, S D, Pitt, B, McGuire, D K, Rossing, P, Ruilope, L M, Butler, J, Jankowska, E A, Michos, E D, Farmakis, D, Farjat, A E, Kolkhof, P, Scalise, A, Joseph, A, Bakris, G L & Agarwal, R 2023, ' Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease ', European heart journal. Cardiovascular pharmacotherapy, vol. 9, no. 1, pp. 85-93 . https://doi.org/10.1093/ehjcvp/pvac054
The Lancet The Lancet, Elsevier, 2019, 394 (10204), pp.1169-1180. ⟨10.1016/S0140-6736(19)31887-2⟩ The Lancet (London), 394, 1169-1180 Bhatt, D L, Steg, P G, Mehta, S R, Leiter, L A, Simon, T, Fox, K, Held, C, Andersson, M, Himmelmann, A, Ridderstråle, W, Chen, J, Song, Y, Diaz, R, Goto, S, James, S K, Ray, K K, Parkhomenko, A N, Kosiborod, M N, McGuire, D K, Harrington, R A & THEMIS Steering Committee and Investigators 2019, ' Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial ', Lancet, vol. 394, no. 10204, pp. 1169-1180 . https://doi.org/10.1016/S0140-6736(19)31887-2 The Lancet (London), 394, 10204, pp. 1169-1180